-
Jinyang Li1，Jiasheng Lu1，Haiyan Guo1，Jianfen Zhou1，Songli Wang1，Kuan Jiang1，Zhilan Chai1，Shengyu Yao1，Xiaoyi Wang1，Linwei Lu2，Cao Xie1，Yi Chen3，Weiyue Lu1,4,2,5（Department of Pharmaceutics，School of Pharmacy，Fudan University & Key Laboratory of Smart Drug Delivery(Fudan University)，Ministry of Education and PLA；The Institutes of Integrative Medicine of Fudan University；Chinese Academy of Sciences Shanghai Institute of Materia Medica；State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science，Institutes of Brain Science，Fudan University；Minhang Branch，Zhongshan Hospital and Institute of Fudan-Minghang Academic Health System，Minghang Hospital，Fudan University）.A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated[J].Acta Pharmaceutica Sinica B,2021,第1期
-
Jingwei Bian1，Zijian Li1,2（Department of Cardiology and Institute of Vascular Medicine，Peking University Third Hospital，Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides，Ministry of Health，Key Laboratory of Molecular Cardiovascular Sciences，Ministry of Education，Beijing Key Laboratory of Cardiovascular Receptors Research；Department of Pharmacy，Peking University Third Hospital）.Angiotensin-converting enzyme 2(ACE2)：SARS-CoV-2 receptor and RAS modulator[J].Acta Pharmaceutica Sinica B,2021,第1期
-
Bingchen Zhang1，Jiali Jiang1，Pengyu Wu1，Junjie Zou1，Jingqing Le1，Juanfang Lin1，Chao Li1，Bangyue Luo1，Yongjie Zhang1，Rui Huang2，Jingwei Shao1,2（Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy，College of Chemistry，Fuzhou University；Institute of Oceanography，Minjiang University）.A smart dual-drug nanosystem based on coassembly of plant and food-derived natural products for synergistic HCC immunotherapy[J].Acta Pharmaceutica Sinica B,2021,第1期
-
Zhibin Yan1，Dan Wang1，Chunmei An1，Hongjiao Xu2，Qian Zhao2，Ying Shi2，Nazi Song2，Bochuan Deng1，Xiaomin Guo1，Jing Rao1，Lu Cheng1，Bangzhi Zhang1，Lingyun Mou1，Wenle Yang1，Xianxing Jiang2，Junqiu Xie1（Key Laboratory of Preclinical Study for New Drugs of Gansu Province，School of Basic Medical Sciences &Research Unit of Peptide Science，Chinese Academy of Medical Sciences，2019RU066，Lanzhou University；School of Pharmaceutical Sciences，Sun Yat-sen University）.The antimicrobial peptide YD attenuates inflammation via miR-155 targeting CASP12 during liver fibrosis[J].Acta Pharmaceutica Sinica B,2021,第1期
-
Yu Sun1，Jiahua Qian2（Department of Traditional Chinese Medicine and Ethnopharmaceuticals，Center for Drug Evaluation，National Medical Products Administration；Center for Drug Evaluation，National Medical Products Administration）.Botanical drug clinical trial：Common issues and future options[J].Acta Pharmaceutica Sinica B,2021,第1期
-
Zeqi Zhou1，Xiangbin Wang2，Yankai Fu1，Xiqing Zhang1，Changxiao Liu3（Dynamiker Biotechnology Sub-Center，Beijing Key Laboratory for Mechanism Study and Precision Diagnosis of Invasive Fungal Diseases；Beijing Antai Zhiyuan Technology Co.，Ltd.；State Key Laboratory of Drug Delivery Technology and Pharmacokinetics，Tianjin Institute of Pharmaceutical Research）.Letter to the editor：Neutralizing antibodies for the treatment of COVID-19[J].Acta Pharmaceutica Sinica B,2021,第1期
-
Editoral Office of Acta Pharmaceutica Sinica（Editoral Office of Acta Pharmaceutica Sinica）.Information for Authors[J].Acta Pharmaceutica Sinica B,2021,第1期
|